Showing results (11-20 of 89) with videos related to

Sort By:
Pageof 9
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|December 8, 2009
Cost-effectiveness analysis of rituximab treatment in patients in Germany with rheumatoid arthritis after etanercept-failureSonja Merkesdal, Timm Kirchhoff, Diane Wolka, et al.
Rheumatology and Therapy|March 5, 2018
A Review of Recent Advances Using Tocilizumab in the Treatment of Rheumatic DiseasesAndrea Rubbert-Roth, Daniel E Furst, Jan Michael Nebesky, et al.
Plos One|December 24, 2010
Effects of inhibition of interleukin-6 signalling on insulin sensitivity and lipoprotein (a) levels in human subjects with rheumatoid diseasesOlaf Schultz, Frank Oberhauser, Jasemine Saech, et al.
Autoimmunity Reviews|November 8, 2017
TNF inhibitors in rheumatoid arthritis and spondyloarthritis: Are they the same?Andrea Rubbert-Roth, Fabiola Atzeni, Ignazio Francesco Masala, et al.
Autoimmunity Reviews|October 23, 2019
Failure of anti-TNF treatment in patients with rheumatoid arthritis: The pros and cons of the early use of alternative biological agentsAndrea Rubbert-Roth, Melinda Zsuzsanna Szabó, Melinda Kedves, et al.
Clinical Rheumatology|June 10, 2010
An open-label pilot study of the efficacy and safety of anakinra in patients with psoriatic arthritis refractory to or intolerant of methotrexate (MTX)Norma Jung, Matthias Hellmann, Reimund Hoheisel, et al.
European Journal of Clinical Investigation|November 29, 2021
Anti-SARS-CoV-2 mRNA vaccines as inducers of humoral response against apolipoprotein A-1?Nicolas Vuilleumier, Sabrina Pagano, Burkhard Ludewig, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 30, 2005
Discovery of the ergothioneine transporterDirk Gründemann, Stephanie Harlfinger, Stefan Golz, et al.
Rheumatology and Therapy|July 20, 2024
Safety and Efficacy of Upadacitinib in Patients with Rheumatoid Arthritis Refractory to Biologic DMARDs: Results Through Week 216 from the SELECT-CHOICE StudyAndrea Rubbert-Roth, Koji Kato, Boulos Haraoui, et al.
Lancet (London, England)|March 25, 2008
Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trialJosef S Smolen, Andre Beaulieu, Andrea Rubbert-Roth, et al.
Pageof 9